早期胃肠癌筛查新进展
New Progress in Early Gastrointestinal Cancer Screening
DOI: 10.12677/ACM.2022.1291237, PDF,    科研立项经费支持
作者: 柴聪敏*, 戴光荣：延安大学附属医院，陕西 延安
关键词: 胃肠癌；早期诊断；筛查；Gastrointestinal Cancer； Early Diagnosis； Screening
摘要: 早期筛查可以有效降低胃肠癌的发病率和病死率，胃肠镜检查是目前筛查胃肠癌的金标准，但早期筛查效果不佳。从患者的血液中寻找新的分子生物标志物在早期胃肠癌筛查中的敏感度和特异度越来越高，有些分子标志物有望成为早期诊断胃肠癌的有效指标，而内镜下早期筛查效果也被发现与特定病变的检出率等质量指标显著相关，该文就这方面的研究进展作一综述。
Abstract: Early screening can effectively reduce the incidence and mortality of gastrointestinal cancer. Gas-troenteroscopy is the current gold standard for screening gastrointestinal cancer, but the early screening effect is not good. From the blood of patients with searching for new molecular bi-omarkers in early gastric cancer screening, sensitivity and specific degree is higher and higher, some molecular markers are expected to become the effective index of the early diagnosis of gastric carcinoma, and early endoscopic screening effect was also found to be significantly associated with the quality indexes such as specific lesion detection rate, this paper presents a review of the re-search progress in this regard.
文章引用：柴聪敏, 戴光荣. 早期胃肠癌筛查新进展[J]. 临床医学进展, 2022, 12(9): 8563-8567. https://doi.org/10.12677/ACM.2022.1291237

参考文献

[1] 张观坡, 柏愚, 李兆申. 结直肠癌早期诊断的分子生物学研究进展[J]. 国际消化病杂志, 2015, 35(4): 247-250.
[2] 左婷婷, 郑荣寿, 曾红梅, 等. 中国胃癌流行病学现状[J]. 中国肿瘤临床, 2017, 44(1): 52-58.
[3] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statis-tics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Can-cer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[4] 王露尧, 张鹭鹭. 中国结直肠癌发病和死亡情况及防控策略[J]. 解放军医院管理杂志, 2021, 28(12): 1195-1197.
[5] Cai, Q., Zhu, C., Yuan, Y., Feng, Q., Feng, Y., Hao, Y., Li, J., Zhang, K., Ye, G., Ye, L., Lv, N., Zhang, S., Liu, C., Li, M., Liu, Q., Li, R., Pan, J., Yang, X., Zhu, X., Li, Y., Lao, B., Ling, A., Chen, H., Li, X., Xu, P., Zhou, J., Liu, B., Du, Z., Du, Y., Li, Z. and Gas-trointestinal Early Cancer Prevention & Treatment Alliance of China (GECA) (2019) Development and Validation of a Prediction Rule for Estimating Gastric Cancer Risk in the Chinese High-Risk Population: A Nationwide Multicentre Study. Gut, 68, 1576-1587. [Google Scholar] [CrossRef] [PubMed]
[6] 王凯悦, 蔡善荣, 张苏展. 不同筛查手段对结直肠腺瘤检出的研究进展[J]. 实用肿瘤杂志, 2022, 37(3): 283-291.
[7] 黄莎, 戴瑨, 高娟娟, 等. 胃癌分子流行病学研究进展[J]. 中国肿瘤临床, 2019, 46(1): 16-21.
[8] 国家消化系统疾病临床医学研究中心, 中华医学会消化内镜学分会, 中华医学会健康管理学分会, 中国医师协会内镜医师分会消化内镜专业委员会, 中国医师协会内镜医师分会消化内镜健康管理与体检专业委员会, 国家消化内镜质控中心, 等. 中国早期胃癌筛查流程专家共识意见(草案) (2017年, 上海) [J]. 中华健康管理学杂志, 2018, 12(1): 8-14.
[9] 中华医学会消化内镜学分会, 中国抗癌协会肿瘤内镜专业委员会. 中国早期胃癌筛查及内镜诊治共识意见(2014年, 长沙) [J]. 中华消化杂志, 2014, 34(7): 433-448.
[10] 倪栋琼, 吕宾, 包海标, 金海峰, 赵晶, 徐毅, 等. 不同血清学危险分层方法在人群早期胃癌筛查中的比较研究[J]. 中华内科杂志, 2019, 58(4): 294-300.
[11] 任明君, 邢利, 唐石伏. 外泌体环状RNA在结直肠癌中应用的研究进展[J]. 中华实用诊断与治疗杂志, 2022, 36(5): 530-533.
[12] Francavilla, A., Turoczi, S., Tarallo, S., Vodicka, P., Pardini, B. and Naccarati, A. (2020) Exosomal mi-croRNAs and Other Non-Coding RNAs as Colorectal Cancer Biomarkers: A Review. Mutagenesis, 35, 243-260. [Google Scholar] [CrossRef] [PubMed]
[13] Luo, H., Zhao, Q., Wei, W., et al. (2020) Circulating Tumor DNA Methylation Profiles Enable Early Diagnosis, Prognosis Prediction, and Screening for Colorectal Cancer. Science Trans-lational Medicine, 12, eaax7533. [Google Scholar] [CrossRef] [PubMed]
[14] Zhao, G., Zhou, A., Li, X., et al. (2021) The Significance of Ex-osomal RNAs in the Development, Diagnosis, and Treatment of Gastric Cancer. Genes (Basel), 12, Article No. 73. [Google Scholar] [CrossRef] [PubMed]
[15] Tang, X.H., Guo, T., Gao, X.Y., et al. (2021) Exosome-Derived Noncoding RNAs in Gastric Cancer: Functions and Clinical Applications. Molecular Cancer, 20, Article No. 99. [Google Scholar] [CrossRef] [PubMed]
[16] Francavilla, A., Turoczi, S., Tarallo, S., Vodicka, P., Pardini, B. and Naccarati, A. (2020) Exosomal microRNAs and Other Non-Coding RNAs as Colorectal Cancer Biomarkers: A Re-view. Mutagenesis, 35, 243-260. [Google Scholar] [CrossRef] [PubMed]
[17] The, J.L., Shabbir, A., Yuen, S. and So, J.B. (2020) Recent Advances in Diagnostic Upper Endoscopy. World Journal of Gastroenterology, 26, 433-447. [Google Scholar] [CrossRef] [PubMed]
[18] Dohi, O., Yagi, N., Majima, A., Horii, Y., Kitaichi, T., Onozawa, Y., Suzuki, K., Tomie, A., Kimura-Tuchiya, R., Tsuji, T., Yamada, N., Bito, N., Okayama, T., Yoshida, N., Kamada, K., Katada, K., Uchiyama, K., Ishikawa, T., Takagi, T., Handa, O., Konishi, H., Naito, Y., Yanagisawa, A., Itoh, Y. (2017) Diagnostic Ability of Magnifying Endoscopy with Blue Laser Imaging for Early Gastric Cancer: A Prospective Study. Gastric Cancer, 20, 297-303. [Google Scholar] [CrossRef] [PubMed]
[19] Mitsala, A., Tsalikidis, C., Pitiakoudis, M., Simopoulos, C. and Tsaroucha, A.K. (2021) Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era. Current Oncology, 28, 1581-1607. [Google Scholar] [CrossRef] [PubMed]
[20] Kaminski, M.F., Wieszczy, P., Rupinski, M., et al. (2017) In-creased Rate of Adenoma Detection Associates with Reduced Risk of Colorectal Cancer and Death. Gastroenterology, 153, 98-105. [Google Scholar] [CrossRef] [PubMed]
[21] Wu, Q., Liu, W., Wang, J., Zhu, L., Wang, Z. and Peng, Y. (2020) Exosomal Noncoding RNAs in Colorectal Cancer. Cancer Letters, 493, 228-235. [Google Scholar] [CrossRef] [PubMed]

为你推荐